ClinicalTrials.govpublic full text
Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection
respiratory syncytial virus prophylaxis, medi-524, motavizumab, respiratory syncytial virus, children, intravenous, rezield, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842546
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.